Potential Side Effects: Potential Side Effects: While GLP-1 receptor agonists offer numerous benefits, they may cause side effects, particularly gastrointestinal issues
Pharmacologically induced slowing of gastric emptying by GLP1RAs should be considered in patients treated with short-acting insulin for appropriate timing of administration of the insulin drug and probable use of rapid rather than ultra-rapid insulin analogues
Those taking the drug can experience rapid weight loss, as well as significant side effects
For example, in the SUSTAIN 5 clinical trial, patients with HbA1c levels of 8.0% or lower had their basal insulin doses reduced by 20% when starting semaglutide therapy to minimize the risk of low blood sugar
If confirmed in larger prospective trials, these widely used drugs could offer a new potential approach to breast cancer prevention, especially for women with excess body weight
Unser Personal wird stndig technisch geschult